Integrative EEG biomarkers predict progression to Alzheimer’s disease at the MCI stage S.-S. Poil, W. de Haan, W.M. van der Flier, H.D. Mansvelder, P. Scheltens and K. Linkenkaer-Hansen. Frontiers in Aging Neuroscience, 3 October 2013. doi: 10.3389/fnagi.2013.00058 Alzheimer’s disease (AD)
We are happy to announce that a new release of the Neurophysiological Biomarker Toolbox is available. We have named the release NBT Alpha RC3b – (Alpha Release Candidate 3b). We hope to release a RC4 very soon with even more
Today 18 April 2013, it is one year since we released the first version of the Neurophysiological Biomarker Toolbox (NBT). To celebrate NBT’s release birthday, we would like to share a bit of statistics and outlook of the future.
We have reached a milestone with 200 users of the Neurophysiological Biomarker Toolbox (NBT) today.
We had not expected such a great success when we released NBT April last year. We are very happy for you support and trust.
NBT has already been used to analyze data for 2 published papers http://l.nbtwiki.net/Vlm6dJ , and many articles in preparation.
We thank all who has given us feedback, which has improved NBT; either on the help mail-list http://l.nbtwiki.net/HRIMOF or our feedback form http://l.nbtwiki.net/JRmxbg .
Currently, we are working hard on improving the statistical functions and the general flow of data in NBT. We still need your feedback! Please join our discussion on LinkedIn “Which statistical tests do miss in NBT?” http://l.nbtwiki.net/YecF08
Please, like us on Facebook http://l.nbtwiki.net/T3RU8f